Biotech Future 2025 On the occasion of the Made in Italy Day, Federchimica Assobiotec and Università degli Studi di Nap...
The impact of the Milleproroghe Decree on biotech research in Italy
Commentary by Giorgio Racagni, Scientific Director ITTBIOMED | EDRA The Milleproroghe Decree is an annual legislative me...
Cancer Patents: Paracchi (Genenta Science) – The U.S. Leads, Europe Follows
In view of World Cancer Day, the European Patent Office (EPO) has published its second study on oncology technologies, p...
Pandemics: Siena Biotech Hub to Coordinate European Network. Projects for 2025
The year 2025 will mark the definitive relaunch of the Siena Biotech Hub Foundation. The Italian government aims to posi...
Liquid Biopsy: ENEA Tech Invests €15 Million in Tethis to Revolutionize Cancer Diagnostics
An Italian innovation promising early diagnosis, less invasive procedures, and personalized care for oncology patients. ...
ENEA Tech and Biomedical Foundation: €160 Million for Precision Medicine, Digital Health, Agritech, Industrial Research, and Experimental Development in Life Sciences
In 2024, the Foundation has allocated approximately €80 million from the Biomedical Fund to invest in 16 innovative st...